Evidence map›Paper›PMID 42326933›Full record

ArticleFrontiers in public health2026

Enhancing chronic disease medicine access through public-private collaboration: insights from community pharmacists.

Pengyeow Loh, Kenneth Kwing-Chin Lee, Renukha Sellappans

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pengyeow LohSchool of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Selangor, Malaysia.
Kenneth Kwing-Chin LeeJeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Selangor, Malaysia.
Renukha SellappansSchool of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Selangor, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Patients with chronic diseases in Malaysia frequently return to public health facilities for their monthly medication supply, contributing to congestion and increased workload. At the same time, community pharmacists remain underutilized due to limited dispensing opportunities. This study explored community pharmacists' perspectives on participating in a public-private partnership model to supply repeat medicines to patients from public health facilities. Methods: A concurrent embedded mixed-methods design was employed, combining a nationwide quantitative survey of 433 community pharmacists with in-depth interviews involving 15 pharmacists from different states. Quantitative data were analyzed using descriptive and inferential statistics, while qualitative interviews underwent thematic analysis. Results: Most community pharmacists perceived community pharmacy-based repeat medicine supply as beneficial, citing patient convenience in terms of accessibility (96.3%), time saving (95.6%) and reduced travel costs (88.5%). They viewed community pharmacies as suitable service points (94.3%) and supported appropriate remuneration for their services (90.6%). Fewer pharmacists considered potential barriers such as increased workload (44.8%), operating costs (39.8%), or space constraints (43.0%). Strongly endorsed facilitators included timely reimbursement to the pharmacists, clear procedures and guidelines, and structured collaboration with public facilities. A high proportion (88.4%) expressed willingness to participate. Qualitative findings reinforced perceived benefits for patients, community pharmacists, and public health system. Participants highlighted the importance of a clear operational framework, efficient reimbursement systems, and avoidance of previous pitfalls in public-private collaborations. While challenges were noted, pharmacists believed these could be mitigated through proper systems including communication platforms, scheduling mechanisms, and defined formularies. Discussion: Overall, community pharmacists demonstrated strong support for participating in repeat medicine supply services. Their motivation stems from patient benefits, professional fulfilment, and commercial sustainability. Realizing this model, however, requires system-level reforms, stakeholder engagement, and robust implementation mechanisms to ensure an effective and sustainable collaboration.

Indexed as

Community Pharmacy ServicesHealth Services AccessibilityPharmacistsPublic-Private Sector PartnershipsAdultAttitude of Health PersonnelChronic DiseaseCooperative BehaviorFemaleHumansInterviews as TopicMalaysiaMaleMiddle AgedSurveys and Questionnaireschronic diseasescommunity pharmacistcommunity pharmacypublic-private partnershiprepeat medicines

Identifiers

PMID42326933
PMCPMC13275434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.